India’s first mRNA vaccine against coronavirus – developed by Pune-based Gennova Biopharmaceuticals Ltd (part of Emcure group of companies) – has been found to be safe and it has been given the go-ahead from the Drugs Controller General of India (DCGI) to move into Phase II and III of clinical trials.

The firm had submitted the interim clinical data of its Phase I trial to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority.
https://indianexpress.com/article/india/indias-first-mrna-vaccine-a...